Zoetis获欧洲委员会批准Portela®(Relfovetmab)用于缓解猫患骨关节炎相关疼痛

投资观察
Oct 29, 2025

Zoetis Inc.:*Zoetis获欧洲委员会批准Portela®(Relfovetmab)用于缓解猫患骨关节炎相关疼痛* Zoetis Inc. - 预计Portela将在2026年在欧盟上市 ((路透社投资简报; email: reutersinvestor.briefs@thomsonreuters.com)) 来源日期/时间 = 29-OCT-2025 12:30:00.16 GMT

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10